Mercodia AB is a Scandinavian biotech company that specializes in the development of immunoassays and bioanalytical services within the area of metabolic disorders. The company was founded in 1991 in Uppsala by Erling Holmlund, a chemist, and entrepreneur from northern Sweden. Erling’s extensive knowledge in the field stems from almost 20 years of experience in immunoassay development within diabetes and cardiovascular disease at Pharmacia Diagnostics. When Pharmacia Diagnostics chose to focus on allergy, Erling took his experience and used it to start a company of his own. With the stringent quality system inherited from Pharmacia Diagnostics, the initial business concept of Mercodia was to develop high-quality ELISAs for use in human diagnostics. The increased demand from pharmaceutical and academic research for reliable assays that ensure reproducible results created interest from researchers around the world for Mercodia’s products. Today Mercodia is a world-leading developer, manufacturer, and distributor of high-quality immunoassay kits. We specialize in ELISAs for clinical as well as research applications, notably within diabetes, obesity, and cardiovascular disease. We offer assays applicable in both human and animal models. Mercodia supplies products to all major international markets from its facilities in Uppsala, Sweden. More than ninety percent of our production is exported to approximately 100 countries worldwide. Mercodia Inc, our US subsidiary, is based in Winston Salem, North Carolina, and is involved in direct sales, distribution, and support to our North American customers. Mercodia provides a professional support system by collaborating with worldwide customers and institutions to develop new applications for existing products and new diagnostics for emerging markets.